000 01306 a2200385 4500
005 20250511201708.0
264 0 _c19910816
008 199108s 0 0 eng d
022 _a0012-6667
024 7 _a10.2165/00003495-199141050-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBlaney, S M
245 0 0 _aCurrent pharmacological treatment approaches to central nervous system leukaemia.
_h[electronic resource]
260 _bDrugs
_cMay 1991
300 _a702-16 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Review
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCentral Nervous System Diseases
_xdrug therapy
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCytarabine
_xadministration & dosage
650 0 4 _aDrug Evaluation
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aLeukemia
_xdrug therapy
650 0 4 _aMeningeal Neoplasms
_xdrug therapy
650 0 4 _aMethotrexate
_xadministration & dosage
700 1 _aBalis, F M
700 1 _aPoplack, D G
773 0 _tDrugs
_gvol. 41
_gno. 5
_gp. 702-16
856 4 0 _uhttps://doi.org/10.2165/00003495-199141050-00003
_zAvailable from publisher's website
999 _c1719106
_d1719106